Heat Biologics Inc (NASDAQ:HTBX)
| 2.64 Delayed Data As of Jan 24 |  -0.07 / -2.58%Today’s Change | 2.45 Today|||52-Week Range 17.00 | -13.16% Year-to-Date |
Latest HTBX News | Press Releases
No recent news for Heat Biologics Inc.
Today’s Trading
| Previous close | 2.71 |
| Today’s open | 2.55 |
| Day’s range | 2.45 - 2.69 |
| Volume | 11,650 |
| Average volume (3 months) | 259,429 |
| Market cap | $68.6M |
Data as of 4:02pm ET, 01/24/2022
Growth & Valuation
| Earnings growth (last year) | +61.29% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -3.32% |
| P/E ratio | NM |
| Price/Sales | 29.06 |
| Price/Book | 0.52 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 2, 2022 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $2.9M |
| Annual profit (last year) | -$26.0M |
| Net profit margin | -883.65% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
